Article Information
History
- August 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Amin Addetia1,
- Katharine HD Crawford2,3,4,
- Adam Dingens2,
- Haiying Zhu1,
- Pavitra Roychoudhury1,5,
- Meei-Li Huang1,5,
- Keith R. Jerome1,5,
- Jesse D. Bloom2,3,6 and
- Alexander L. Greninger1,5,#
- 1Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA
- 2Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA
- 3Department of Genome Sciences, University of Washington, Seattle, WA
- 4Medical Scientist Training Program, University of Washington, Seattle, WA
- 5Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
- 6Howard Hughes Medical Institute, Seattle, WA
- ↵#Corresponding author, agrening{at}uw.edu
Posted August 14, 2020.
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate
